Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.2-<0.9
General Information
Revision date
2022-09-02
Product name
EPZICOM TABLETS
Product Synonyms
EPZICOM 600 MG/300 MG TABLETS * KIVEXA 600 MG/300 MG TABLETS * ABC/3TC COMBINATION TABLETS * ABACAVIR SULFATE AND LAMIVUDINE, FORMULATED PRODUCT
1.2.2. Uses advised against
No other uses are advised
Manufacturer Name
2_HEADER_HAZARD_IDENTIFICATION
Icons in SDS
Company Information
company name
2_HEADER_HAZARD_IDENTIFICATION
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified.
Health hazards
Germ cell mutagenicity Category 2 Carcinogenicity Category 2 Reproductive toxicity Category 2 Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, acute Category 3 Hazardous to the aquatic environment, Category 3
Signal word
Warning
Hazard statements
Suspected of causing genetic defects. Suspected of causing cancer. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Harmful to aquatic life. Harmful to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.
Response
IF exposed or concerned: Get medical advice/attention.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
24.265 % of the mixture consists of component(s) of unknown acute oral toxicity. 98.965 % of the mixture consists of component(s) of unknown acute dermal toxicity. 96.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 49.365 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 28.165 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
